… ProQR Announces Expert Perspectives Call on LCA10 and … & CAMBRIDGE, Mass., July 13, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … presentation by Aniz Girach, MD, Chief Medical Officer of ProQR Therapeutics. Dr. Girach will then discuss the …
… ProQR Prices $75 Million Underwritten Public Offering and … (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”), a company dedicated to changing lives through … and commissions and other offering expenses payable by ProQR. All of the shares are being offered by ProQR. In …
… ProQR Announces Annual General Meeting of Shareholders and … & CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a …
… ProQR Announces Results for the Fourth Quarter and Full Year … and full year 2015. “2015 was a year of execution for ProQR. From the inception of ProQR in 2012, we had been … study is also assessing sweat chloride, weight gain, CFQ-R Respiratory Symptom Score and lung function, measured by …
… ProQR Therapeutics to Host Virtual R&D Event on March 29, 2023 LEIDEN, Netherlands & CAMBRIDGE, … (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through …
… ProQR Announces Webcast of Presentation at Upcoming HC … will be accessible from the “Investors & Media” section of ProQR’s website ( www.proqr.com ) under ‘Events’, beginning January 11, 2021. …